Cannara Biotech, Inc. · TSX:LOVE
Cannara Biotech — Investor Presentation (December 2024)
19 slides from Cannara Biotech's investor presentation, December 2024
Slide 1: Premium-Grade Cannabis at Scale
TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 PREMIUM-GRADE CANNABIS AT SCALE INVESTOR DECK FISCAL 2024 (AS OF AUGUST 31, 2024)
Slide 2: Disclaimer
General Disclaimer This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the information contained in the Company’s most recent Annual Information Form, as well as in the Company’s most recent consolidated financial statements, together with the notes
Slide 3: Forward-Looking Statements
General Forward-Looking Statements This presentation may contain “forward-looking information” within the meaning of Canadian securities legislation (“forward-looking statements”). These forward-looking statements are made as of the date of this presentation and the Company does not intend, and does
Slide 4: Corporate Overview
Corporate Overview Vertically-integrated Licensed Producer of premium-grade cannabis and cannabis-derivative products Canada’s 8th Top LP by sales1 Financials BC AB • YTD gross cannabis revenues SK MB ONT QC Overview before excise taxes of $110.2M NS 4th largest producer based and Net income of $6.4
Slide 5: Canadian Recreational Cannabis Market
Canadian Recreational Cannabis Market 2ND Largest Cannabis Market in the world Legal Cannabis Market expected Monthly Retail Sales of Legal to reach Cannabis Stores in Canada from US$6.58 billion by 20291 October 2018 to October 20242 7 Retail sales in million CDN dollars Overview 500 6 450 Market s
Slide 6: Two Quebec Based Mega Facilities
Two Quebec Based Mega Facilities Completely automated equipped with cutting edge technologies Overview Strategy Financials Leadership Summary Farnham Facility Valleyfield Facility • 625,000 sq. ft. facility provides 170,000 sq. ft. • One of the largest indoor cannabis Each activated zone has of cann
Slide 7: Why Quebec
Why Quebec Average Electricity Rates By Province In Cents Per Kw Hour 3.7¢/kWh Cannara Preferred Rate Quebec has the lowest electricity rates in Canada QC MB BC SK ON NS AB 5.3¢/kWh 5.9¢/kWh 7.7¢/kWh 8.9¢/kWh 9.8¢/kWh 11.4¢/kWh 13.6¢/kWh Overview Strategy Financials Quebec has the highest barriers L
Slide 8: Competitive Advantage
Competitive Advantage Quality, Scalability & Transparency Innovation in Products & Genetics • Deliver true to craft like procedures including hang drying and • Continue to innovate with new product launches. hand trimming cannabis to ensure quality. • Identify unique THC and CBD cultivars to fill •
Slide 9: Delivering Premium Quality Cannabis
Delivering Premium Quality Cannabis Focusing on high cannabinoid content and rich flavourful cannabis Our cannabis is grown using Rare genetics Hang dried & slow cured methods inspired by the most Overview sophisticated markets in the world: Strategy Financials Leadership Summary Quality Accessibili
Slide 10: Portfolio of Brands
Portfolio of Brands - Overview Strategy Financials Leadership Summary Q4 FY2024 10
Slide 11: Cannara Strategy
Cannara Strategy Delivering a premium-quality product at scale and at lower prices for consumers is at the heart of our strategy Purposeful growth by focusing on the Canadian legal market that is expected to reach US$6.58 billion by 20291 Overview Respond to market demand by increasing production ca
Slide 12: Annualized Production (kg)
Production Assets Cannara’s Estimated Annual Production Capacity in kg 80,000 75,000 70,000 Overview 62,500 Annualized Production (kg) Strategy 60,000 Financials 50,000 Leadership 50,000 Summary 39,500 40,000 33,500 30,500 30,000 22,000 20,000 10,000 0 FY2022 FY2023 FY2024 FY2025 FY2026 FY2027 FY202
Slide 13: Scaling Production & Sales
Scaling Production & Sales Cannabis Production & Revenue Growth Trajectory as Valleyfield Production Scales Up 1 1 Overview $22.1 Strategy Financials $18.8 $18.3 $18.5 Leadership $17.2 Summary $14.9 $12.0 $11.1 $9.2 $9.4 1 Cannabis KG and equivalent of cannabis KG for derivatives products Q4 FY2024
Slide 14: Increasing Our Market Share
Increasing Our Market Share October 2024 – Highest National Top-performing Products Market Share to-date of 3.8% Retail Market Share Overview Province October 2024 Q4 2024 Q3 2024 #1 Quebec’s #1 Infused pre-rolls #1 Strategy QC 12.6% 11.9% 9.7% Canada’s #1 Live resin vape cart brand Financials Leade
Slide 15: FY 2024 Selected Financial Information
FY 2024 Selected Financial Information For the year ended August 31, 2024 Current Capitalization Table $81.7M 90,018,952 $27.9 Overview 34% Strategy $15.1 5,166,600 Financials Leadership $6.4M Summary $10.7M 2,219,183 $3.2M $6.6M $40.5M Term loan and Credit facility with BMO supporting growth of Can
Slide 16: Executive Leadership Team
Executive Leadership Team Zohar is an entrepreneur who has Nicholas is a CPA with an Avi has been in the launched several successful businesses. entrepreneurial spirit and information technology He has founded, advised and invested passion for the Cannabis industry for over 20 years. He in numerous
Slide 17: Executive Leadership Team
Executive Leadership Team ZOHAR KRIVOROT MARY DUROCHER CHAIRMAN & CEO DIRECTOR Zohar is a seasoned entrepreneur who has built and grown Mary has been involved in the cannabis industry since the infancy of the Marijuana multiple successful businesses. He has played pivotal roles for Medical Purposes
Slide 18: In Summary Positioned for National Success
In Summary Well capitalized, fast-growing business Operating with strong margins and with an established history of execution with a focus on positive EBITDA, cash flow and profitability Offering customers the highest value Overview products at disruptive low prices Strategy State of the art Quebec
Slide 19: Thank You
TSXV: LOVE | OTCQB: LOVFF | FRA: 8CB0 THANK YOU Overview Strategy www.cannara.ca Financials Leadership Summary investors.cannara.ca www.instagram.com/cannarabiotech www.facebook.com/cannarabiotech CANNARA HEADQUARTERS FARNHAM FACILITY VALLEYFIELD FACILITY 333 Decarie blvd, Suite 200 1144 Boulevard M
Cannara Biotech — Investor Presentation (December 2024) on 6ix